- 详细介绍
- 资料下载
- 相关产品
- 购买说明
英文名：Triantennary GalNAc Ligand（三触角 GalNAc 配体）
品牌：BOC
规格：100mg
产品说明：三触角 GalNAc 配体是与生物素、抗体或抗体片段缀合的配体，可产生一类新的降解剂。它已用于靶向药物输送，例如寡核苷酸治疗。
产地：美国
包装容器：西林瓶/塑料瓶
无菌处理：/
保存条件：零下20°C
保质期限：12个月
| 产品信息 | |
| 产品名称 | Triantennary GalNAc Ligand |
| 货号 | BL-M001376 |
| CAS号 | 1159408-63-5 |
| IUPAC名称 | [(2R,3R,4R,5R,6R)-5-acetamido-6-[5-[3-[3-[3-[3-[3-[5-[(2R,3R,4R,5R,6R)-3-acetamido-4,5-diacetyloxy-6-(acetyloxymethyl)oxan-2-yl]oxypentanoylamino]propylamino]-3-oxopropoxy]-2-[[3-[3-[5-[(2R,3R,4R,5R,6R)-3-acetamido-4,5-diacetyloxy-6-(acetyloxymethyl)oxan-2-yl]oxypentanoylamino]propylamino]-3-oxopropoxy]methyl]-2-(phenylmethoxycarbonylamino)propoxy]propanoylamino]propylamino]-5-oxopentoxy]-3,4-diacetyloxyoxan-2-yl]methyl acetate |
| 同义词 | Tri-GalNAc(OAc)3 Cbz; 5-Oxa-2,9,13-triazaoctadecanoic acid, 8,14-dioxo-3,3-bis[[3-oxo-3-[[3-[[1-oxo-5-[[3,4,6-tri-O-acetyl-2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]pentyl]amino]propyl]amino]propoxy]methyl]-18-[[3,4,6-tri-O-acetyl-2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-, phenylmethyl ester; Phenylmethyl 8,14-dioxo-3,3-bis[[3-oxo-3-[[3-[[1-oxo-5-[[3,4,6-tri-O-acetyl-2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]pentyl]amino]propyl]amino]propoxy]methyl]-18-[[3,4,6-tri-O-acetyl-2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-5-oxa-2,9,13-triazaoctadecanoate; Tri-b-GalNAcAc3-NHCbz; Tri-GalNAc (Cbz, peracetylated); Tris-GalNAc (Cbz, peracetylated); Tris-β-GalNAc-Cbz (perac); Tris-GalNAcAc3-Cbz; tri-β-GalNAcAc3-NHCbz; Triantennary β-GalNAcAc3-NHCbz |
| 纯度 | >95% |
| 储存条件 | 零下20°C |
| SMILES | CC(=O)NC1C(C(C(OC1OCCCCC(=O)NCCCNC(=O)CCOCC(COCCC(=O)NCCCNC(=O)CCCCOC2C(C(C(C(O2)COC(=O)C)OC(=O)C)OC(=O)C)NC(=O)C) (COCCC(=O)NCCCNC(=O)CCCCOC3C(C(C(C(O3)COC(=O)C)OC(=O)C)OC(=O)C)NC(=O)C)NC(=O)OCC4=CC=CC=C4)COC(=O)C)OC(=O)C)OC(=O)C |
| InChI | InChI=1S/C87H134N10O38/c1-52(98)94-74-80(130-61(10)107)77(127-58(7)104)65(46-123-55(4)101)133-83(74)120-39-19-16-27-68(110)88-33-22-36-91-71(113)30-42-117-49-87(97-86(116)126-45-64-25-14-13-15-26-64,50-118-43-31-72(114)92-37-23-34-89-69(111)28-17-20-40-121-84-75(95-53(2)99)81(131-62(11)108)78(128-59(8)105)66(134-84)47-124-56(5)102)51-119-44-32-73(115)93-38-24-35-90-70(112)29-18-21-41-122-85-76(96-54(3)100)82(132-63(12)109)79(129-60(9)106)67(135-85)48-125-57(6)103/h13-15,25-26,65-67,74-85H,16-24,27-51H2,1-12H3,(H,88,110)(H,89,111)(H,90,112)(H,91,113)(H,92,114)(H,93,115)(H,94,98)(H,95,99)(H,96,100)(H,97,116)/t65-,66-,67-,74-,75-,76-,77+,78+,79+,80-,81-,82-,83-,84-,85-/m1/s1 |
| InChI Key | JMCXVEFCNXSLCI-ZTLRGGSLSA-N |
纳米医学网还提供相关合成脂质产品：
| 产品简称 | CAS |
产品简称 |
CAS |
|---|---|---|---|
| SM-102 | 2089251-47-6 |
Cholesterol (from plant) |
57-88-5 |
| D-Lin-MC3-DMA | 1224606-06-7 |
DOPC |
4235-95-4 |
| DSPC | 816-94-4 |
DOPE |
4004-05-1 |
| mPEG2000-DMG | 160743-62-4 |
DOPG-NA |
66857-21-8 |
| ALC-0315 | 2036272-55-4 |
DOPS-NA |
70614-14-1 |
| DOTAP chloride | 132172-61-3 |
DPPA-NA |
57299-49-5 |
|
DLin-KC2-DMA |
1190197-97-7 |
DPPC |
63-89-8 |
| ALC-0159 | 1849616-42-7 |
DPPE |
923-61-5 |
| CKK-E12 | 1432494-65-9 |
DPPS-NA |
71319-00-9 |
| C14-4 | 2639634-80-1 |
DSPA-NA |
14455-19-5 |
|
DODAP |
127512-29-2 | DMPC |
18194-24-6 |
|
DSG-PEG2000 |
308805-39-2 |
DPPG-NA | 67232-81-9 |
|
DOTAP methylsulfate |
144189-73-1 | DOPA-NA |
108392-02-5 |
|
G0-C14 |
1510653-27-6 | DSPE |
1069-79-0 |
|
DODMA |
104162-47-2 |
HSPC | 92128-87-5 |
|
DC-Chol hydrochloride |
166023-21-8 |
PMPC | 63119-37-9 |
|
DLin-DMA |
871258-12-7 |
POPC | 26853-31-6 |
| LNP-Lipid 8 |
2408140-60-1 |
POPE | 10015-88-0 |
|
Lipid 8 |
2226547-25-5 | POPG |
81490-05-3 |
|
Fluorescent DOTAP |
1010076-97-7 | SOPC |
56421-10-4 |
| DSPE-PEG2000-Mal | 474922-22-0 |
Alkyne Cholesterol |
1631985-09-5 |
|
DSPE-PEG2000-Biotin |
385437-57-0 |
C16 PEG2000 Ceramide |
212116-78-4 |
| DSPE-PEG-Folate | 1236288-25-7 |
Cholesterol-PEG2000-MAL |
N/A |
上海舜纳生物科技有限公司 纳米医学技术研发中心 Sunlipo Biotech Research Center for Nanomedicine
邮箱：sunlipotech@163.com（技术服务）info@med-nanotech.com（应用开发）
电话：86-21-5127 9909 传真：86-21-5193 6393
